** Shares of Bubs Australia BUB.AX climb as much as 6.1%
to A$0.175, set for best day since Oct 11 if current trend holds
** Dairy firm reports 3.4% rise in group gross revenue for
Q1 to A$24.3 mln ($15.39 mln), driven by strong performance in
U.S. business
** Says U.S. Federal Drug Administration permanent access
process remains on track with clinical trials underway
** Stock hits highest level since Oct 19
** Stock had fallen 45% this year, as of last close
($1 = 1.5788 Australian dollars)
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))